Samtidig var hyppigheden af CNS- blødninger 1, 5% i løbet af den 28 - dages forsøgsperiode.
18 In the open-label ENHANCE study, the incidence of serious bleeding events during the 28-day study period was 6.5%, and the incidence of CNS bleeds during the 28-day study period was 1.5%.